Effect of taxifolin on development of retinopathy in alloxan-induced diabetic rats. (3rd July 2019)
- Record Type:
- Journal Article
- Title:
- Effect of taxifolin on development of retinopathy in alloxan-induced diabetic rats. (3rd July 2019)
- Main Title:
- Effect of taxifolin on development of retinopathy in alloxan-induced diabetic rats
- Authors:
- Ahiskali, Ibrahim
Pinar, Can Lokman
Kiki, Murat
Mammadov, Renad
Ozbek Bilgin, Asli
Hacimuftuoglu, Ahmet
Cankaya, Murat
Keskin Cimen, Ferda
Altuner, Durdu - Abstract:
- Abstract: Purpose: Diabetic retinopathy (DR) is one of the leading causes of blindness. In DR patients, antioxidant defence is disrupted, and production of reactive oxygen species and pro-inflammatory cytokines such as interleukin 1β (IL-1β) and tumour necrosis factor alpha (TNF-α) increases. Taxifolin has been reported to suppress reactive oxygen species, IL-1β and TNF-α production. The aim of this study is to biochemically and histopathologically examine the protective effect of taxifolin against DR damage induced by alloxan. Materials and methods: Alloxan received rats with a blood glucose level of ≥250 mg/dL were divided into taxifolin-treated (TAX) ( n = 6), diabetic control (DC) ( n = 6) groups. There were rats received only saline in non-diabetic control (NC) group ( n = 6). Taxifolin (50 mg/kg) was orally administered to the TAX group rats. DC and NC rats received the same volume of saline as a solvent. This procedure was repeated once a day for 3 months. At the end of this period, animals were killed by high dose thiopental sodium anaesthesia. Histopathological examinations were then performed on excised rat eyes. Malondialdehyde (MDA), total glutathione (tGSH), IL-1β and TNF-α levels were measured in obtained blood samples. Results: MDA, IL-1β and TNF-α levels were significantly increased in blood samples of DC group rats with hyperglycemia induced by alloxan compared with NC group ( p < 0.0001), and decreased in the TAX group compared with the DC group ( pAbstract: Purpose: Diabetic retinopathy (DR) is one of the leading causes of blindness. In DR patients, antioxidant defence is disrupted, and production of reactive oxygen species and pro-inflammatory cytokines such as interleukin 1β (IL-1β) and tumour necrosis factor alpha (TNF-α) increases. Taxifolin has been reported to suppress reactive oxygen species, IL-1β and TNF-α production. The aim of this study is to biochemically and histopathologically examine the protective effect of taxifolin against DR damage induced by alloxan. Materials and methods: Alloxan received rats with a blood glucose level of ≥250 mg/dL were divided into taxifolin-treated (TAX) ( n = 6), diabetic control (DC) ( n = 6) groups. There were rats received only saline in non-diabetic control (NC) group ( n = 6). Taxifolin (50 mg/kg) was orally administered to the TAX group rats. DC and NC rats received the same volume of saline as a solvent. This procedure was repeated once a day for 3 months. At the end of this period, animals were killed by high dose thiopental sodium anaesthesia. Histopathological examinations were then performed on excised rat eyes. Malondialdehyde (MDA), total glutathione (tGSH), IL-1β and TNF-α levels were measured in obtained blood samples. Results: MDA, IL-1β and TNF-α levels were significantly increased in blood samples of DC group rats with hyperglycemia induced by alloxan compared with NC group ( p < 0.0001), and decreased in the TAX group compared with the DC group ( p < 0.0001). The levels of tGSH were significantly decreased in blood samples of DC group rats compared with NC group ( p < 0.0001), and increased in the TAX group compared with the DC group ( p < 0.0001). Histopathologically, retinal ganglion cells of the TAX group had a slightly dilated and congested blood vessel, and severe damage was inflicted to the retinal ganglion cell layer of the DC group. Conclusions: Experimental results suggest that taxifolin may be beneficial in the treatment of DR. … (more)
- Is Part Of:
- Cutaneous and ocular toxicology. Volume 38:Number 3(2019)
- Journal:
- Cutaneous and ocular toxicology
- Issue:
- Volume 38:Number 3(2019)
- Issue Display:
- Volume 38, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 38
- Issue:
- 3
- Issue Sort Value:
- 2019-0038-0003-0000
- Page Start:
- 227
- Page End:
- 232
- Publication Date:
- 2019-07-03
- Subjects:
- Alloxan -- diabetic retinopathy -- retina toxicity -- taxifolin -- rat
Dermatotoxicology -- Periodicals
Ocular toxicology -- Periodicals
Ocular pharmacology -- Periodicals
Dermatopharmacology -- Periodicals
Toxicology -- Periodicals
615.9 - Journal URLs:
- http://informahealthcare.com/journal/cot ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/15569527.2019.1588289 ↗
- Languages:
- English
- ISSNs:
- 1556-9527
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3506.146900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11252.xml